Standard Biotools (LAB) Capital Expenditures Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | -93.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.69% |
| Dec 31, 2025 | -893.63% |
| Sep 30, 2025 | 149.69% |
| Jun 30, 2025 | -2.58% |
| Mar 31, 2025 | 547.12% |
| Dec 31, 2024 | 131.93% |
| Sep 30, 2024 | -297.02% |
| Jun 30, 2024 | 131.15% |
| Mar 31, 2024 | -22.67% |
| Dec 31, 2023 | -464.64% |
| Sep 30, 2023 | -28.40% |
| Jun 30, 2023 | -10.66% |
| Mar 31, 2023 | 16.36% |
| Dec 31, 2022 | 51.00% |
| Sep 30, 2022 | -90.13% |
| Jun 30, 2022 | -91.55% |
| Mar 31, 2022 | -87.46% |
| Dec 31, 2021 | -95.33% |
| Sep 30, 2021 | 3,676.11% |
| Jun 30, 2021 | 1,630.89% |
| Mar 31, 2021 | 572.14% |
| Dec 31, 2020 | 2,041.40% |
| Sep 30, 2020 | -74.81% |
| Jun 30, 2020 | 52.98% |
| Mar 31, 2020 | 287.22% |
| Dec 31, 2019 | 2,400.00% |
| Sep 30, 2019 | 579.80% |
| Jun 30, 2019 | 444.16% |
| Mar 31, 2019 | 245.45% |
| Dec 31, 2018 | -88.76% |
| Sep 30, 2018 | -64.26% |
| Jun 30, 2018 | -45.77% |
| Mar 31, 2018 | -88.87% |
| Dec 31, 2017 | -74.35% |
| Sep 30, 2017 | -67.58% |
| Jun 30, 2017 | -90.65% |
| Mar 31, 2017 | -39.51% |
| Dec 31, 2016 | -51.70% |
| Sep 30, 2016 | 627.23% |
| Jun 30, 2016 | 8.35% |
| Mar 31, 2016 | 25.85% |
| Dec 31, 2015 | -3.17% |
| Sep 30, 2015 | -82.67% |
| Jun 30, 2015 | -49.05% |
| Mar 31, 2015 | -49.86% |
| Dec 31, 2014 | -21.11% |
| Sep 30, 2014 | 107.66% |
| Jun 30, 2014 | 1,185.05% |
| Mar 31, 2014 | 159.74% |
| Dec 31, 2013 | 146.53% |
| Sep 30, 2013 | 70.94% |
| Jun 30, 2013 | -74.58% |
| Mar 31, 2013 | 75.82% |
| Dec 31, 2012 | 12.37% |
| Sep 30, 2012 | 34.98% |
| Jun 30, 2012 | 70.45% |
| Mar 31, 2012 | 80.45% |
| Dec 31, 2011 | 66.01% |
| Sep 30, 2011 | -40.04% |